Bonefos ODAC meeting cancelled

Schering (FSE:SCH; SHR) subsidiary Berlex Laboratories said the FDA cancelled the Dec. 2 meeting at which the Oncology Drugs Advisory Committee was to discuss an NDA for Bonefos clodronate. The compou...